Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

IJ Pharmaceutical Research

homeHome
play_arrowCurrent Issueformat_list_bulletedAll Issuesformat_indent_increaseIn Presscheck_boxAccepted Manuscripts
searchSearchqr_codeInstructions
bookmarkJournal InformationgroupsEditors & BoardsshareIndexing and Listing Sourceswaterfall_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
menuAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development

- Ghasemiyeh P. , et al.

2. A cross-sectional study on the potential drug-drug interaction risk of COVID-19 patients in hospital

- Huang L.L. , et al.

3. Drug–Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?

- Bourdin V. , et al.

4. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics

- Gupta Y. , et al.

5. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2

- Firouzabadi N. , et al.

6. A Brief Review of Pharmacokinetic Assessments of Vancomycin in Special Groups of Patients with Altered Pharmacokinetic Parameters

- Ghasemiyeh P. , et al.

7. Senna makki and other active phytochemicals: Myths and realities behind covid19 therapeutic interventions

- Zaman N. , et al.